Advertisement

Topics

Ocular Surface Center, P.A. Company Profile

18:43 EDT 20th September 2018 | BioPortfolio

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that are important for treating ocular surface diseases. Under the leadership of the President, Billy K. Yeh, M.D., Ph.D., OSF supports research and educational programs that may create a differentiable value in treating these diseases. OSF believes that one way of accomplishing this mission is to promote the education and training of young ophthalmologists that will be specialized in the diagnosis and treatment of these diseases. OSF also believes that one important way of gaining such new knowledge and skills is through effective research and educational programs

Location

7000 SW 97th Ave,Suite 213
Miami
Florida
33173
United States of America

Contact

Phone: (305) 274-1299
Fax: (305) 274-1297
Email: stseng@ocularsurface.com


News Articles [905 Associated News Articles listed on BioPortfolio]

Vitiligo with ocular involvement associated with dry eye

Periocular involvement in vitiligo may make patients more susceptible to dry eye than those with vitiligo without ocular involvement, according to a study.A single-center, cross-sectional observationa...

Ocular surface squamous neoplasia seen in congenital ichthyosis

Ocular surface squamous neoplasia, or OSSN, is seen often as an abnormal growth in the ocular surface predominantly near the limbus. Immunosuppression and ultraviolet light exposure are known high ris...

Punctal Plug Deemed Beneficial in Ocular Surface Disease

FRIDAY, May 4, 2018 -- For patients with ocular surface disease (OSD) using prostaglandin analogue monotherapy, a punctal plug improves OSD and reduces intraocular pressure (IOP), according to a study...

Ocular Therapeutix files third NDA for ocular pain drug

A new drug application was filed for the third time by Ocular Therapeutix for Dextenza, or dexamethasone insert, 0.4 mg to tr -More- 

Quotidian Technical Highlights on Selected Biotech Stocks -- Ocular Therapeutix, Onconova ...

www.wallstequities.com/registration Ocular Therapeutix On Monday, shares in Bedford, Massachusettsheadquartered Ocular Therapeutix Inc. recorded a trading volume of 158,186 shares. The stock ended...

Microsoft stellt Surface Hub 2 vor

SAN FRANCISCO (IT-Times) - Der US-Softwarekonzern Microsoft Corp. hat mit dem Surface Hub 2 eine neue und zweite Version des digitalen Flipcharts Surface Hub präsentiert. Das Surface Hub 2 ist eine.....

Surface Oncology closes $11.5mm PIPE concurrent with IPO

Surface Oncology Inc. (cancer immunotherapies) grossed $11.5mm through a private placement of 766,666 common shares at $15 apiece to Novartis Institutes for BioMedical Research. The PIPE closed concur...

Read OSN's March 25 publication exclusives online

The cover story of the March 25 issue of Ocular Surgery News focused on managing ocular injuries. Here are some of the issue’s publication exclusives: Cover storyUrgency prevails in management of b...

Drugs and Medications [401 Associated Drugs and Medications listed on BioPortfolio]

Puralube [Fera Pharmaceuticals]

Drug Facts

Sterilube ointment [Fera Pharmaceuticals]

DRUG FACTS

Akten [Akorn, Inc.]

These highlights do not include all the information needed to use AKTEN safely and effectively. See full prescribing information for AKTEN. AKTEN (lidocaine hydrochloride) gel for ophthalmic use Initi...

Bacitracin [Rebel Distributors Corp]

BACITRACIN OPHTHALMICOINTMENT USPSTERILE

Bacitracin ophthalmic ointment usp sterile [E. FOUGERA and CO.]

BACITRACIN OPHTHALMIC OINTMENT USP STERILE

PubMed Articles [2528 Associated PubMed Articles listed on BioPortfolio]

Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease.

To describe changes in visual acuity in patients fit with the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) with irregular corneas compared to those with ocular surface disease, as well a...

Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.

To evaluate long-term ocular surface clinical signs and symptoms response to therapy in patients with chronic ocular GVHD.

Antiglaucomatous treatments and ocular surface.

the antiglaucomatous treatments interact with the ocular surface and can induce its alteration which may affect the therapeutic results Aim : to describe the interactions between the ocular surface an...

A Review of the Cytokine IL-17 in Ocular Surface and Corneal Disease.

To investigate the role of interleukin-17 in ocular surface and corneal disease. Ocular surface and corneal disease is a leading cause of blindness and is an ongoing challenge for the public health se...

Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease.

While the normal cornea has limited innervation by the lymphatic system, chronic immune-inflammatory disorders such as dry eye (DE) can induce lymphangiogenesis in the ocular surface. Using a conditio...

Clinical Trials [3323 Associated Clinical Trials listed on BioPortfolio]

Surveillance of Ocular Surface Flora (SURFACE)

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteri...

Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease

Dry eye syndrome and ocular surface disease are very important ophthalmologic diseases. It is known that various inducers are involved. However, it is still necessary to study how influenc...

Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome

The study aims to compare the differences of ocular surface features in controls and patients with diabetes and dry eye syndrome, to thoroughly evaluate the ocular surface health of diabet...

Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens Wear

Our study is aimed to observe the long termed effect of contact lens wear on ocular surface, especially focused on visual function and ocular inflammation mediators.

Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.

Companies [1639 Associated Companies listed on BioPortfolio]

Ocular Surface Center, P.A.

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that ar...

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Biohedron.Inc.

Visualizing Protein Complexes• A Pair of Polyhedra• Surface Buried in an Interface• Computing a Surface Between Two Densities• Polyhedra Evaluated at an Interfacial Surface• Densities Evalua...

More Information about "Ocular Surface Center, P.A." on BioPortfolio

We have published hundreds of Ocular Surface Center, P.A. news stories on BioPortfolio along with dozens of Ocular Surface Center, P.A. Clinical Trials and PubMed Articles about Ocular Surface Center, P.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ocular Surface Center, P.A. Companies in our database. You can also find out about relevant Ocular Surface Center, P.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record